posted
just got back home.....looks like some playing going on between .075 and .082, not too many going to be shaken out imo,far too many good things in the works.
posted
I think I am not worried in the least about this one,should have more loose money from selling FMLY to place here.
from the other board!
When these lot have something to say, they say it...no mystery, no conspiracy, just the workings of a good company, confident about it's own image and standing IMO.
Tue, Jun 13, 2006
5:00 AM CalbaTech Posts Letter to Shareholders on Achievements, Future Business Strategies - PR Newswire
Tue, May 30, 2006
5:00 AM CalbaTech Contributes to Key Effort Supporting Stem Cell Research to Cure Diabetes, Other Major Diseases - PR Newswire
Mon, May 08, 2006
5:02 PM CalbaTech Announces Increase in Revenues to $412K, Company Posts a Net Profit in First Quarter, Expects Net Profit in Current Fiscal Year - PR Newswire
Mon, Apr 03, 2006
7:40 PM CalbaTech Announces Significant Revenue Increase in 2005; Forecasts Profitability in 2006 and Expects to See Continued Progress by Its Subsidiary LifeStem With Its Stem Cell Microbank(TM) Service - PR Newswire
Fri, Mar 10, 2006
12:39 PM CalbaTech Subsidiary, K-D Medical, Inc.: A Day in the Life - PR Newswire
Fri, Mar 03, 2006
5:00 AM CalbaTech, and Its Stem Cell Subsidiary, LifeStem, Inc., Note Significant Progress in Using Stem Cells to Treat Heart Disease - PR Newswire
Mon, Feb 27, 2006
5:00 AM CalbaTech, Through Its Subsidiary, Lifestem, Inc., Enthusiastically Notes the Stem Cell Study Center to Be Established at USC; Lifestem is in the Exact Right Place for Stem Cell Services - PR Newswire
Thu, Feb 16, 2006
1:58 PM CalbaTech's Subsidiary, LifeStem, Inc., Moving Forward With Its Stem Cell MicroBank(TM), Says Adult Stem Cell Research Promises Major Breakthroughs - PR Newswire
Wed, Dec 28, 2005
FILING An amendment to a previously filed 10QSB - Form 10QSB/A FILING Amendment to a previously filed 8-K - Form 8-K/A
posted
Solana hopes to break out of the swell of spas with what it bills as a unique service: stem cell collection. Although the research is largely unproven, adult stem cells are seen by some as offering potential for treating heart disease, Parkinson’s disease, diabetes, Alzheimer’s disease and spinal cord injuries.
Solana has teamed with Irvine-based CalbaTech Inc. to collect stem cells at some of its spa locations. CalbaTech is a biotech company that’s part owner of Solana.
Solana draws stem cells from the abdomen for $3,000. The service is being offered in La Quinta and Pasadena. It plans to roll out stem cell collection to its 18 California locations, said Chief Executive John Buckingham, who codeveloped a spa management program at the University of California, Irvine.
Local investor John Garcia, who had his stem cells banked 10 years ago theold-fashioned way—they were painfully extracted from bone marrow—put Solana and CalbaTech together, Buckingham said. Garcia is founding principal of Tustin-based Angel Strategies LLC, which has invested in Solana.
Solana said it expects to have 38 spas open by the end of June and about 50 by the end of 2006.
Solana MedSpas’ overall strategy includes continually evaluating new technologies and services that will exclusively deliver leading edge products and services to its client / owners. A stunning example is their recent agreement with LifeStem, Inc., to offer its Stem Cell MicroBank Service through select locations in the Solana MedSpas network, making Solana MedSpas the first medical spa network to offer an adult stem cell collection service. Recent research indicates that autologous (one’s own) adult stem cells hold the potential for treatment, cure and possible prevention of numerous afflictions such as heart disease, Parkinson’s Disease, diabetes, Alzheimer’s disease, and spinal cord injuries. LifeStem, Inc., headquartered in Irvine, Calif., is a wholly owned subsidiary of CalbaTech, Inc. (OTC Bulletin Board: CLBE), a publicly traded emerging life sciences company concentrating on providing products and platforms to the research market for biotech and pharmaceutical companies and to academic institutions.
dding and finally found the info concerning prentice article posted here and the types of things that can actually be treated with adult cells ....while looking for this info i found another article that was talking about how it has taken 50 years of adult stem cell research/testing just to come up with the approved treatments they now have - wow!!
Adult Stem Cell Treatments for Diseases Shane Smith, William Neaves, Steven Teitelbaum
posted
check out this link and just look at all the openings NOW on the right side of the home page! This may be what IR has been so optimistic about lately!!
and just think...CalbaTech is a biotech company that’s part owner of Solana!
People aged 35 - 50 had the most procedures done - 44% of total. 75% of U.S. population age 35-65 has some treatable, pigmented lesion. Men account for 25% of medspa procedures and the trend continues to grow. In just the female age group 22 – 34, there were 2 million users from only 1,000 suppliers – demand far exceeds supply and is expected to continue for 20 years.
Independent Market Data
Dr. Marian Luban, CEO MedSpa Alliance – “No other firm in the MedSpa industry has figured out how to pull off a national MedSpa business development program.”
International Spa Association – “MedSpas have grown 147% in last five years – highest growth of any spa type!”
Dr. Robert Keller of the Pebble Beach, California Skin Institute cites three factors to understand the phenomenal growth in the MedSpa industry:
• The alternative medicine movement: Dr. Andrew Weil • The physical structure of spas are already in place • The baby boomers now make up 51% of total U.S. population
The spa industry is growing at an incredible rate, with experts pegging the average revenue increase at 114%. This astonishing growth is attributed to the demand for the “stress-free” environment, a place where people can escape the frantic, daily grind. The spa industry registers 155.8 million visits every year with a steady triple figure annual growth seen within the next 10 years. In 2004, the spa industry accounted for $11.2 billion in revenues.
12,000 Americans turn 50 every day (1 every 8 seconds!) and this will continue for the next 20 years. Studies show the number of Americans over 55 will grow by 60% in the next 20 years and their buying power will exceed $2 trillion by 2007. In addition, within the next five years, boomers will experience the biggest transference of wealth in U.S. history, making them wealthier.
posted
a question was brought up about CBAI being CLBE's competetion, I contacted Paul and heres his reply.
Cord Blood is also our client. CLBE told me last night: "real soon."
Paul
Quest Solver wrote:
Good morning Paul,
It looks like another company is trying to be a little more competitive with CalbaTech, they are CBAI-CORD BLOOD AMERICA INC can we compete with them on their stem banking?
posted
I am buying more at this price. Don't people realize this is adult stem cells?
Posts: 438 | From: just outside of nowhere | Registered: Mar 2006
| IP: Logged |
posted
Illinois' governor announced Thursday he was diverting $5 million from the state budget for stem cell research, despite repeated objections from state legislators.
The move came a day after President Bush vetoed federal legislation that would have expanded funding for embryonic stem cell research.
Illinois lawmakers have previously voted down stem cell funding over ideological differences, and this spring they didn't take up the governor's proposal for $100 million in funding over five years.
"Investing in research that can save lives and prevent serious illnesses is more than a sound public health strategy, it's our moral obligation," Gov. Rod Blagojevich, a Democrat, said in a statement Thursday.
The money will come out of administrative funds already set aside for the state Department of Healthcare and Family Services, Blagojevich said.
Stem cells are building blocks that turn into different types of tissue. Embryonic stem cells are able to turn into any tissue, given the right biochemical instructions. Scientists hope to harness them to regenerate damaged organs or other body parts.
Many opponents of the research consider embryonic stem cells to be early human life
A day after President Bush vetoed expanded federal funding of embryonic stem cell research, Gov. Arnold Schwarzenegger on Thursday authorized a $150 million loan to fund California's stem cell institute, which has been stalled by lawsuits.
Schwarzenegger, a Republican who has been trying to put distance between himself and the unpopular president as he seeks re-election this year, said the state cannot afford to wait to fund the critical science associated with stem cells.
"I remain committed to advancing stem cell research in California, in the promise it holds for millions of our citizens who suffer from chronic diseases and injuries that could be helped as a result of stem cell research," Schwarzenegger said in a letter to his finance director.
The state's voters created the California Institute for Regenerative Medicine in 2004 when they passed a ballot measure that authorized $3 billion over 10 years for stem cell research.
Lawyers with ties to anti-abortion and anti-tax groups have sued, arguing that the institute is unconstitutional.
On April 21, a Superior Court judge ruled the institute was a legitimate state agency. But if opponents continue to contest the agency in court, they could hold up the institute's financing until at least next year.
Elsewhere, Illinois Gov. Rod Blagojevich, a Democrat, announced Thursday that he is diverting $5 million from the state budget for stem cell research, despite repeated objections from state legislators.
"Investing in research that can save lives and prevent serious illnesses is more than a sound public health strategy, it's our moral obligation," he said.
The money will come out of administrative funds already set aside for the state Department of Healthcare and Family Services, Blagojevich said.
Illinois lawmakers have previously voted against stem cell research, and this spring they did not take up the governor's proposal for $100 million in funding over five years.
Embryonic stem cells are building blocks that turn into different types of tissue. Scientists hope to use them someday to regenerate damaged organs or other body parts and cure diseases. Some oppose such research because it entails the destruction of human embryos.
posted
CLBE has a lot to say and I believe Medspa's is going to be a big part of it.
Solana said it expects to have 38 spas open by the end of June and about 50 by the end of 2006.
Solana has teamed with Irvine-based CalbaTech Inc. to collect stem cells at some of its spa locations. CalbaTech is a biotech company that’s part owner of Solana.
Why should people buy now? The chart shows it is going lower. Its possible to daytrade but the volume is still low. It needs news to take off from here.
(OTCBB: CLBE) CalbaTech, Inc., a life sciences company, provides products and platforms to the research market for biotech and pharmaceutical companies, as well as to academic institutions. Through its three divisions, Molecular Applications, Research Reagents, and Cellular Therapeutics, as well as wholly owned subsidiaries, including Molecula, Inc.; KD Medical, Inc.; LifeStem, Inc.; and MolecularWare, Inc., the company is developing products and technologies in biological discovery. The Molecular Applications division has an active program of molecular biology applications and research, including pathogen microarrays, diagnostics, electronic-based DNA detection systems, and DNA sample preparation. The Research Reagents division provides cell and molecular biology reagents and related consumables. It develops and sells research reagents for cell transfection, DNA and RNA purification, protein expression, gene expression analysis, and other fundamental products. The Cellular Therapeutics division focuses on cellular applications, particularly those relating to the use of adult stem cells. It includes cell-based research projects for the delivery of cell-based clinical therapies.
As a trader, a very intelligent place to put your money, is where the money is flowing into. These are the kind of trades that you want to get into.
posted
Hi, Stockmover. The chance to get it under 0.04 is very small. The MMs have been accumulating CLBE shares for the last 10 months. They will raise the pps gradually to unload their shares. Now is the dip of the first small run, a bigger run is expected soon.
Posts: 3228 | From: Michigan | Registered: Aug 2005
| IP: Logged |
posted
Am working with them on the language in a release. Won't be today; Friday is for bad news.
Paul
GOVERNMENTSUPPLYLINE wrote:
sorry I didn't quite understand that reply, did you mean A.M.?? Like monday morning, or did you mean to say you are working with them?
Just curious... I bought up 400K shares today from .052 to .07, I believe in this company but people have been waiting on stem cell banking news for some time. Please let me know if you can specify when you think it will be out.
----- Original Message ----- From: Paul Knopick To: GOVERNMENTSUPPLYLINE Sent: Friday, July 21, 2006 12:52 PM Subject: Re: Stem Cell Banking
Am working with them.
Paul
Posts: 165 | From: pennyland | Registered: May 2006
| IP: Logged |